NCT02412254

Brief Summary

The investigators will conduct a small pilot study that will randomize \~ 40 70-84 year-old adults with hearing loss to best-practices hearing rehabilitative treatment (hearing assessment, counseling, fitting of amplification devices) versus a successful aging intervention (one-on-one counseling/education sessions on successful aging topics). Participants will be followed for 6 months, and outcomes will focus on communication, quality of life, cognition, and other functional surveys. This pilot study is in preparation for a larger planned trial to investigate if hearing loss treatment can reduce cognitive decline and dementia in older adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 9, 2015

Completed
22 days until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2021

Completed
Last Updated

April 8, 2021

Status Verified

March 1, 2021

Enrollment Period

5.9 years

First QC Date

April 1, 2015

Last Update Submit

April 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hearing Handicap Inventory for the Elderly (HHIE)

    6 month follow-up

Secondary Outcomes (1)

  • Neurocognitive test battery including Trail Making Test, Delayed Word Recall, and other tests

    6 months

Study Arms (2)

Hearing intervention

ACTIVE COMPARATOR

Best practices hearing rehabilitative treatment

Other: Best practices hearing rehabilitative treatment

Successful aging intervention

PLACEBO COMPARATOR

Successful aging intervention

Other: Successful aging intervention

Interventions

Intervention comprises hearing needs assessment, counselling, sensory management with amplification devices, and rehabilitative training.

Hearing intervention

One-on-one education sessions on healthy aging topics (cancer screening, smoking cessation, etc.) between a trainer and participant

Successful aging intervention

Eligibility Criteria

Age70 Years - 84 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 70-84 years.
  • Community-dwelling.
  • Fluent English-speaker.
  • Residency. Participants must plan to reside in the local area for the study duration (6 months).
  • Audiometric hearing impairment. Participants must have adult-onset hearing impairment with a pure tone average (0.5, 1, and 2 kHz) in the better-hearing ear of ≥ 30 decibels and \<70 dB.
  • Word Recognition in Quiet score \>60% bilaterally.
  • Mini-Mental State Exam (MMSE) score ≥ 23 for individuals with high-school degree or less; Mini-Mental State Exam (MMSE) score ≥ 25 for individuals with some college or more
  • Willingness to participate. Participants must be willing and able to consent to participate in the study, be willing to be randomized to either the Hearing intervention or to the Successful Aging intervention, and be willing to follow the study protocol for the duration of the trial.

You may not qualify if:

  • Potential candidates for enrollment who meet one or more of t he following criteria are excluded from participation in the study:
  • Self-reported disability in ≥ 2 or more Activities of Daily Living (ADL)
  • Self-reported hearing aid use in the past year (\>5 hours/week).
  • Vision impairment (worse than 20/40 on MN Near Vision Card).
  • Medical contraindication to use of hearing aids (e.g., draining ear).
  • Conductive hearing impairment as determined by a difference in air audiometry and bone audiometry ("air-bone gap") greater than 15 dB in 2 or more contiguous frequencies in both ears.
  • Unwilling to wear hearing aids on a regular (i.e., daily or near daily) basis
  • No participants are excluded based on race or sex

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Comstock Center for Public Health Research

Hagerstown, Maryland, 21740, United States

Location

Related Publications (1)

  • Deal JA, Albert MS, Arnold M, Bangdiwala SI, Chisolm T, Davis S, Eddins A, Glynn NW, Goman AM, Minotti M, Mosley T, Rebok GW, Reed N, Rodgers E, Sanchez V, Sharrett AR, Coresh J, Lin FR. A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study. Alzheimers Dement (N Y). 2017 Jun 21;3(3):410-415. doi: 10.1016/j.trci.2017.06.003. eCollection 2017 Sep.

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Frank Lin

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2015

First Posted

April 9, 2015

Study Start

May 1, 2015

Primary Completion

March 8, 2021

Study Completion

March 8, 2021

Last Updated

April 8, 2021

Record last verified: 2021-03

Locations